This is exemplified in individuals with cystic fibrosis and patients with hereditary pancreatitis due to mutations in PRSS1 or SPINK1, who have an increased risk of pancreatic cancer due to chronic inflammation and related changes in the pancreas [2,79,80]. Here, PRSS1 is linked to pancreatic neoplasm.